1. Home
  2. APYX vs EQ Comparison

APYX vs EQ Comparison

Compare APYX & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apyx Medical Corporation

APYX

Apyx Medical Corporation

HOLD

Current Price

$4.10

Market Cap

159.0M

Sector

Health Care

ML Signal

HOLD

EQ

Equillium Inc.

HOLD

Current Price

$2.21

Market Cap

129.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APYX
EQ
Founded
1982
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
159.0M
129.0M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
APYX
EQ
Price
$4.10
$2.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$6.50
$8.00
AVG Volume (30 Days)
222.2K
267.6K
Earning Date
05-07-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
19.40
N/A
EPS
N/A
N/A
Revenue
N/A
$41,095,000.00
Revenue This Year
$11.93
N/A
Revenue Next Year
$11.01
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.34
$0.29
52 Week High
$4.50
$2.70

Technical Indicators

Market Signals
Indicator
APYX
EQ
Relative Strength Index (RSI) 58.22 52.20
Support Level $3.39 $1.60
Resistance Level $4.28 $2.42
Average True Range (ATR) 0.37 0.20
MACD 0.10 0.02
Stochastic Oscillator 81.52 34.33

Price Performance

Historical Comparison
APYX
EQ

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: